tradingkey.logo

cbdMD Inc

YCBD
1.490USD
-0.440-22.80%
收盘 12/19, 16:00美东报价延迟15分钟
13.27M总市值
亏损市盈率 TTM

cbdMD Inc

1.490
-0.440-22.80%

关于 cbdMD Inc 公司

cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

cbdMD Inc简介

公司代码YCBD
公司名称cbdMD Inc
上市日期Nov 17, 2017
CEOKennedy (T. Ronan)
员工数量42
证券类型Ordinary Share
年结日Nov 17
公司地址8845 Red Oak Blvd
城市CHARLOTTE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编28217-5593
电话17044453060
网址https://www.cbdmd.com/
公司代码YCBD
上市日期Nov 17, 2017
CEOKennedy (T. Ronan)

cbdMD Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
2.23K
+239.63%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
2.12K
+286.34%
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
2.23K
+239.63%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
2.12K
+286.34%
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
业务USD
名称
营收
占比
E-commerce sales
3.58M
77.70%
Wholesale sales
1.03M
22.30%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
E-commerce sales
3.58M
77.70%
Wholesale sales
1.03M
22.30%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Crc Investment Fund LP
13.10%
Kennedy (Thomas Ronan)
4.82%
CSS, LLC
1.51%
Chapin Davis Asset Management
1.29%
Porter (Jeffrey H)
0.78%
其他
78.50%
持股股东
持股股东
占比
Crc Investment Fund LP
13.10%
Kennedy (Thomas Ronan)
4.82%
CSS, LLC
1.51%
Chapin Davis Asset Management
1.29%
Porter (Jeffrey H)
0.78%
其他
78.50%
股东类型
持股股东
占比
Corporation
13.84%
Individual Investor
7.24%
Investment Advisor
4.75%
Investment Advisor/Hedge Fund
0.13%
其他
74.03%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
51
502.25K
5.64%
+188.29K
2025Q2
61
1.71M
19.14%
+1.55M
2025Q1
80
154.62K
3.22%
-19.13K
2024Q4
76
811.68K
23.02%
+42.15K
2024Q3
80
869.63K
30.51%
+134.84K
2024Q2
85
734.40K
27.03%
-50.91K
2024Q1
91
757.62K
28.39%
-18.50K
2023Q4
95
764.16K
29.72%
+83.63K
2023Q3
108
684.81K
27.23%
+10.72K
2023Q2
117
634.68K
40.66%
-58.78K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Crc Investment Fund LP
1.23M
13.84%
+1.23M
--
May 06, 2025
Kennedy (Thomas Ronan)
9.31K
0.1%
+8.48K
+1023.40%
May 06, 2025
CSS, LLC
142.62K
1.6%
+142.62K
--
Jun 30, 2025
Chapin Davis Asset Management
118.63K
1.33%
+118.63K
--
Jun 30, 2025
Porter (Jeffrey H)
73.26K
0.82%
+73.26K
--
May 16, 2025
Alesco Advisors LLC
68.51K
0.77%
+68.51K
--
Jun 30, 2025
Coffman (Raymond Scott)
48.46K
0.54%
--
--
Feb 21, 2025
Lambeth (Marianne)
46.70K
0.52%
--
--
Feb 21, 2025
Commonwealth Financial Network
16.25K
0.18%
+16.25K
--
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Cambria Cannabis ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Amplify Seymour Cannabis ETF
0%
Cambria Cannabis ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
Amplify Seymour Cannabis ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Apr 21, 2025
Merger
8→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
公告日期
类型
比率
Apr 21, 2025
Merger
8→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1

常见问题

cbdMD Inc的前五大股东是谁?

cbdMD Inc 的前五大股东如下:
Crc Investment Fund LP持有股份:1.23M,占总股份比例:13.84%。
Kennedy (Thomas Ronan)持有股份:9.31K,占总股份比例:0.10%。
CSS, LLC持有股份:142.62K,占总股份比例:1.60%。
Chapin Davis Asset Management持有股份:118.63K,占总股份比例:1.33%。
Porter (Jeffrey H)持有股份:73.26K,占总股份比例:0.82%。

cbdMD Inc的前三大股东类型是什么?

cbdMD Inc 的前三大股东类型分别是:
Crc Investment Fund LP
Kennedy (Thomas Ronan)
CSS, LLC

有多少机构持有cbdMD Inc(YCBD)的股份?

截至2025Q3,共有51家机构持有cbdMD Inc的股份,合计持有的股份价值约为502.25K,占公司总股份的5.64%。与2025Q2相比,机构持股有所增加,增幅为-13.51%。

哪个业务部门对cbdMD Inc的收入贡献最大?

在FY2025Q3,E-commerce sales业务部门对cbdMD Inc的收入贡献最大,创收3.58M,占总收入的77.70%。
KeyAI